D. George

Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1).

N. Rofsky, D. Alsop, M. Michaelson, 2005, Academic radiology.

Combined T2* and T1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement

N. Rofsky, D. Alsop, M. Michaelson, 2006, European Radiology.

Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma1

David C. Alsop, Neil M. Rofsky, Guillaume Duhamel, 2005 .

Magnetic Resonance Imaging–Measured Blood Flow Change after Antiangiogenic Therapy with PTK787/ZK 222584 Correlates with Clinical Outcome in Metastatic Renal Cell Carcinoma

Ivan Pedrosa, David C Alsop, Neil M Rofsky, 2008, Clinical Cancer Research.

Magnetic Resonance Imaging ^ Measured Blood Flow Change after AntiangiogenicTherapy with PTK 787 / ZK 222584 Correlates with Clinical Outcome inMetastatic Renal Cell Carcinoma

N. Rofsky, D. Alsop, I. Pedrosa, 2008 .

Decreases in free cholesterol and fatty acid unsaturation in renal cell carcinoma demonstrated by breath-hold magnetic resonance spectroscopy.

R. Lenkinski, N. Rofsky, R. Marquis, 2005, American journal of physiology. Renal physiology.